Drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.
This Article is From Jun 12, 2020
Zydus Cadila Signs Pact With Gilead To Make Remdesivir
Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.
.
